Skip to main content

Table 3 Factors associated with positive oral HPV DNA at univariable and multivariable analysis

From: Oral human Papillomavirus DNA detection in HIV-positive men: prevalence, predictors, and co-occurrence at anal site

 

Positive HPV DNA (n/total)

Univariate analysis

Multivariable analysis§

OR (95% CI)

p

aOR (95% CI)

p

Age, years

  ≥ 45

26/146

1

 

1

 

  < 45

38/159

1.45 (0.83–2.54)

0.193

1.09 (0.59–2.00)

0.791

Current use of recreational drugs

 No or former

49/258

1

 

1

0.422

 Yes

15/47

2.0 (1.01–3.98)

0.048*

1.36 (0.64–2.90)

 

Current cigarette smoking

 No or former

28/160

1

   

 Yes

36/145

1.58 (0.89–2.71)

0.118

  

Duration of HIV infection, years

  < 2

11/55

1

   

 2–4

13/80

0.78 (0.32–1.89)

0.576

  

  > 4

35/142

1.23 (0.58–2.61)

0.587

  

cART

 No

4/16

1

   

 Yes

60/289

0.79 (0.25–2.52)

0.686

  

CD4+ cell count/μl

  ≥ 200

58/297

1

 

1

 

  < 200

6/8

12.36 (2.43–62.83)

0.002*

12.58 (2.19–72.30)

0.005*

HIV RNA, copies/mL,

 Not detected or detectable ≤40

52/268

1

0.072

1

0.277

  > 40

12/37

1.99 (0.94–4.23)

 

1.59 (0.69–3.70)

 

Type of sexual partner

 Heterosexual

5/33

1

   

 Homosexual

28/135

1.47 (0.52–4.14)

0.471

  

 Bisexual

31/137

1.64 (0.58–4.60)

0.349

  

N. of sexual partners in lifetime

  < 10

2/27

1

   

 10–100

14/126

1.56 (0.33–7.32)

0.571

  

  > 100

48/152

5.77 (1.31–25.35)

0.020*

  

N. of sexual partners in the last 12 months

 0–1

16/120

1

 

1

 

 2–5

17/80

1.75 (0.83–3.72)

0.143

2.01 (0.90–4.49)

0.090

  > 5

31/105

2.72 (1.39–5.34)

0.004*

2.78 (1.30–5.93)

0.008*

Oral sex

 No or insertive

3/30

1

   

 Receptive/both

61/275

2.57 (0.75–8.74)

0.132

  

Anal HPV DNA

 Negative

5/45

1

 

1

 

 Positive

59/260

2.35 (0.89–6.22)

0.086

1.72 (0.63–4.68)

0.289

History of anal/genital condylomatosis

 No

33/193

1

 

1

 

 Yes

31/112

1.86 (1.06–3.24)

0.030*

1.42 (0.78–2.58)

0.252

  1. OR odds ratio, aOR adjusted odds ratio, cART combination antiretroviral therapy
  2. § In the model all variables found to be associated with positive oral HPV DNA at univariate analysis at p < 0.10 were included, forcing age. The variable “N. of sexual partner in the previous 12 months” instead of “N. of sexual partners in lifetime” was used to avoid collinearity
  3. * p < 0.05; ‡ p < 0.10